CoChat
Sign Up
Cited by 280Celiac Disease Research and ManagementGastrointestinal motility and disordersInflammatory Bowel Disease

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome

Open access
Wahnschaffe, Ulrich, Ullrich, R., Riecken, E.O., Schulzke, J.D.·2001·Gastroenterology
DOI 10.1053/gast.2001.29572
Open this paper in CoChat — free accountOpen PDF

Abstract

Background & aims Abdominal symptoms in the absence of mucosal abnormalities are features of both the irritable bowel syndrome (IBS) and latent/potential celiac disease (cd). To identify a possible subgroup of IBS patients with latent/potential cd, surrogate markers of cd were investigated in IBS patients.Methods IBS patients suffering from diarrhea (n = 102), and patients with active cd (n = 10), treated cd (n = 26), and latent cd (n = 5) were included in the study. We measured serum immunoglobulin (Ig) A against gliadin and tissue-transglutaminase, and IgA and IgM against gliadin, tissue-transglutaminase (intestinal cd-associated antibodies), and the dietary proteins beta-lactoglobulin and ovalbumin in duodenal aspirate by enzyme-linked immunosorbent assay. Intraepithelial lymphocytes (IELs) were counted in histology sections, and the expression of HLA-DQ2 (A1*0501/B1*0201) was investigated by polymerase chain reaction. In 26 IBS patients, the effect of 6 months of gluten withdrawal was examined.Results Most cd patients expressed HLA-DQ2 and had increased intestinal cd-associated antibodies, whereas cd-associated serum IgA and IEL counts were increased in active cd in contrast to treated or latent cd. In IBS patients, 35% were HLA-DQ2-positive, 23% had increased IEL counts, and 0% and 30% had increased cd-associated antibodies in serum and duodenal aspirate, respectively. Furthermore, stool frequency and intestinal IgA decreased significantly under a gluten-free diet in the subgroups of HLA-DQ2-positive and intestinal antibody-positive IBS patients when compared with IBS patients without these markers.Conclusions HLA-DQ2 expression and increased intestinal cd-associated antibodies are markers that can identify latent/potential cd in a subgroup of IBS patients who consequently appear to profit from a gluten-free diet.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/gast.2001.29572

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 35 references

Cited by

Sorted by citations

Items 201–278 of 278

Related

See all

Metadata

Authors
Wahnschaffe, U., Ullrich, R., Riecken, E. O., & Schulzke, J. D.
Affiliations
Freie Universität Berlin (DE)
ORCID
Schulzke, J.D.
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2001-12
Volume
121
Issue
6
Pages
1329-1338
ISSN
0016-5085 (ISSN-L)
DOI
10.1053/gast.2001.29572
OpenAlex
W2169133758
Cited by
280
References
35
Citations by year
2025: 2 · 2024: 1 · 2023: 23 · 2022: 5 · 2021: 10 · 2020: 4 · 2019: 7 · 2018: 10 · 2017: 5 · 2016: 9 · 2015: 13 · 2014: 16 · 2013: 17 · 2012: 15
FWCI
13.18
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords
irritable bowel syndrome, celiac disease, latent celiac disease, HLA-DQ2, intraepithelial lymphocytes, anti-tissue transglutaminase antibodies, anti-gliadin antibodies, duodenal aspirate, gluten-free diet, gluten withdrawal, intestinal IgA, β-lactoglobulin, ovalbumin, diarrhea, surrogate markers
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Antigens, Celiac Disease, Colonic Diseases, Functional, Diet, Duodenum, Female, Gliadin, Humans, Immunoglobulin A, Immunoglobulin M, Lactoglobulins, Male, Middle Aged, Ovalbumin, Transglutaminases, Reticulin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review